Pralsetinib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pralsetinib
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Pralsetinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 USDMF, 3 NDC API, 1 Listed Suppliers, $ API Reference Price

3 API Suppliers
2 USDMF
3 NDC API
1 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 33 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
33 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 4 US Exclusivities

5 US Patents
4 US Exclusivities

$ API Ref.Price (USD/KG) : 184,370 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5RIGEL PHARMS

filter Patent Number Reset all filters

5 All

01 210030005

02 111273160

03 111872192

04 111963958

filter API Patent Reset all filters

5 All

01 2Y

02 3Blank

filter FDF Patent Reset all filters

5 All

01 2Y

02 3Blank

filter Expiration Date Reset all filters

5 All

01 22036-11-01

02 32039-04-03

Product Main Page

01

RIGEL PHARMS

PharmaVenue

Not Confirmed

RIGEL PHARMS

Country

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-01

PRALSETINIB

US Patent Number : 10030005

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213721

Patent Use Code : U-2952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-11-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

RIGEL PHARMS

PharmaVenue

Not Confirmed

RIGEL PHARMS

Country

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-01

PRALSETINIB

US Patent Number : 10030005

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213721

Patent Use Code : U-3002

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-11-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

RIGEL PHARMS

PharmaVenue

Not Confirmed

RIGEL PHARMS

Country

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-03

PRALSETINIB

US Patent Number : 11273160

Drug Substance Claim :

Drug Product Claim :

Application Number : 213721

Patent Use Code : U-2952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

RIGEL PHARMS

PharmaVenue

Not Confirmed

RIGEL PHARMS

Country

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-03

PRALSETINIB

US Patent Number : 11872192

Drug Substance Claim :

Drug Product Claim :

Application Number : 213721

Patent Use Code : U-2952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

RIGEL PHARMS

PharmaVenue

Not Confirmed

RIGEL PHARMS

Country

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-03

PRALSETINIB

US Patent Number : 11963958

Drug Substance Claim :

Drug Product Claim :

Application Number : 213721

Patent Use Code : U-2828

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?